Editorial For reprint orders, please contact [removed] Immune modulation in Pompe disease treated with enzyme replacement therapy Expert Rev. Clin. Immunol. 8(6), 497–[removed])

First Page		Document Content
Date: 2013-05-26 18:40:15 Anatomy Immune system Glycoproteins Glycogen storage disease type II Hepatology Rituximab Antibody Lysosomal storage disease Intravenous immunoglobulin Medicine Biology Immunology		Editorial For reprint orders, please contact [removed] Immune modulation in Pompe disease treated with enzyme replacement therapy Expert Rev. Clin. Immunol. 8(6), 497–[removed]) Add to Reading List Source URL: amdapompe.ehclients.com Download Document from Source Website File Size: 612,60 KB Share Document on Facebook

$PROTOCOLOTratamiento con Medicamentos Biológicos, Abatacept o Rituximab en adultos con Artritis Reumatoide refractaria al tratamiento habitual$	PROTOCOLOTratamiento con Medicamentos Biológicos, Abatacept o Rituximab en adultos con Artritis Reumatoide refractaria al tratamiento habitual DocID: 1trGJ - View Document
	Oncogene, 3530–3540 & 2004 Nature Publishing Group All rights reserved $25.00 www.nature.com/onc Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 DocID: 1tpiT - View Document
	NOVEMBER 2015 TABLE OF CONTENTS INTRODUCTION DocID: 1qUAB - View Document
	www.edoriumjournals.com CASE REPORT PEER REVIEWED \| OPEN ACCESS DocID: 1qwuZ - View Document
	Zevalin Enlarged PI (Page 2) DocID: 1qhPE - View Document